Marvin B. Cohen

1.5k total citations
53 papers, 1.1k citations indexed

About

Marvin B. Cohen is a scholar working on Molecular Biology, Oncology and Hematology. According to data from OpenAlex, Marvin B. Cohen has authored 53 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 14 papers in Oncology and 9 papers in Hematology. Recurrent topics in Marvin B. Cohen's work include Cancer Treatment and Pharmacology (11 papers), Biochemical and Molecular Research (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Marvin B. Cohen is often cited by papers focused on Cancer Treatment and Pharmacology (11 papers), Biochemical and Molecular Research (7 papers) and Colorectal Cancer Treatments and Studies (6 papers). Marvin B. Cohen collaborates with scholars based in United States, Germany and United Kingdom. Marvin B. Cohen's co-authors include Adrianne Bendich, Wolfgang Sadée, Ralph R. Weichselbaum, Jacob Rotmensch, Jeffrey L. Schwartz, Leonard Spolter, R. Lake, Howard S. Höchster, Stephen C. Suffin and Milton E. Rubini and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Gastroenterology.

In The Last Decade

Marvin B. Cohen

50 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marvin B. Cohen United States 18 367 363 137 131 126 53 1.1k
K. Pollow Germany 24 248 0.7× 391 1.1× 55 0.4× 93 0.7× 140 1.1× 124 1.8k
Tohru Yamazaki Japan 18 284 0.8× 702 1.9× 64 0.5× 158 1.2× 128 1.0× 48 1.7k
Sylvie G. Bernier United States 21 194 0.5× 918 2.5× 81 0.6× 158 1.2× 87 0.7× 47 1.7k
Thomas Schöndorf Germany 21 341 0.9× 590 1.6× 63 0.5× 71 0.5× 145 1.2× 71 1.4k
Aarti Asnani United States 21 393 1.1× 488 1.3× 107 0.8× 128 1.0× 107 0.8× 59 1.4k
Vojtech Ličko United States 19 182 0.5× 455 1.3× 221 1.6× 82 0.6× 51 0.4× 50 1.3k
Mari Ishida Japan 26 243 0.7× 1.3k 3.6× 147 1.1× 162 1.2× 218 1.7× 91 2.5k
Takeo Tanaka Japan 25 196 0.5× 611 1.7× 115 0.8× 68 0.5× 144 1.1× 82 1.6k
A J Farrell United Kingdom 12 75 0.2× 267 0.7× 103 0.8× 113 0.9× 93 0.7× 13 1.2k
Xin Wei China 22 329 0.9× 574 1.6× 58 0.4× 111 0.8× 176 1.4× 92 1.8k

Countries citing papers authored by Marvin B. Cohen

Since Specialization
Citations

This map shows the geographic impact of Marvin B. Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marvin B. Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marvin B. Cohen more than expected).

Fields of papers citing papers by Marvin B. Cohen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marvin B. Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marvin B. Cohen. The network helps show where Marvin B. Cohen may publish in the future.

Co-authorship network of co-authors of Marvin B. Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Marvin B. Cohen. A scholar is included among the top collaborators of Marvin B. Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marvin B. Cohen. Marvin B. Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Grace, Rachael F., D. Mark Layton, Frédéric Galactéros, et al.. (2017). Results Update from the DRIVE PK Study: Effects of AG-348, a Pyruvate Kinase Activator, in Patients with Pyruvate Kinase Deficiency. Blood. 130. 2194–2194. 2 indexed citations
2.
3.
Clemens, Pamela L., Jong-Soon Park, Marvin B. Cohen, et al.. (2009). Abstract A101: BMS-754807, an oral dual IGF-1R/IR inhibitor: First-in-human single-dose study of safety, tolerability, pharmacokinetics, and pharmacodynamics in healthy subjects. Molecular Cancer Therapeutics. 8(12_Supplement). A101–A101. 2 indexed citations
4.
Faivre, Sandrine, Catherine Delbaldo, Valérie Boige, et al.. (2008). Safety of repeated administrations of ixabepilone given as a 3-hour infusion every other week in combination with irinotecan in patients with advanced malignancies. European Journal of Cancer. 44(5). 674–682. 7 indexed citations
5.
Levy, Adam, Paul A. Meyers, Leonard H. Wexler, et al.. (2008). Phase 1 and pharmacokinetic study of concurrent carboplatin and irinotecan in subjects aged 1 to 21 years with refractory solid tumors. Cancer. 115(1). 207–216. 10 indexed citations
6.
Plummer, Ruth, Penella J. Woll, D. Fyfe, et al.. (2008). A Phase I and Pharmacokinetic Study of Ixabepilone in Combination with Carboplatin in Patients with Advanced Solid Malignancies. Clinical Cancer Research. 14(24). 8288–8294. 12 indexed citations
7.
Gadgeel, Shirish M., Antoinette J. Wozniak, Ramesh Boinpally, et al.. (2005). Phase I Clinical Trial of BMS-247550, A Derivative of Epothilone B, Using Accelerated Titration 2B Design. Clinical Cancer Research. 11(17). 6233–6239. 59 indexed citations
8.
Malhotra, Bimal, Ramaswamy A. Iyer, Wei‐Chi Liao, et al.. (2001). Oral Bioavailability and Disposition of [14C]Omapatrilat in Healthy Subjects. The Journal of Clinical Pharmacology. 41(8). 833–841. 8 indexed citations
9.
Cohen, Marvin B., et al.. (1992). SPECT Brain Imaging in Alzheimer??s Disease during Treatment with Oral Tetrahydroaminoacridine and Lecithin. Clinical Nuclear Medicine. 17(4). 312–315. 11 indexed citations
10.
Bendich, Adrianne & Marvin B. Cohen. (1990). Ascorbic acid safety: analysis of factors affecting iron absorption. Toxicology Letters. 51(2). 189–201. 37 indexed citations
11.
Schwartz, Jeffrey L., et al.. (1988). Faster repair of DNA double-strand breaks in radioresistant human tumor cells. International Journal of Radiation Oncology*Biology*Physics. 15(4). 907–912. 119 indexed citations
12.
Cohen, Marvin B.. (1987). Selection and characterization of mycophenolic acid-resistant leukemia cells. Somatic Cell and Molecular Genetics. 13(6). 627–633. 6 indexed citations
13.
Cooney, David A., et al.. (1987). A simple method for the rapid determination of the stereospecificity of NAD-dependent dehydrogenases applied to mammalian IMP dehydrogenase and bacterial NADH peroxidase. Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology. 916(1). 89–93. 9 indexed citations
14.
Ahluwalia, Gurpreet S., Marvin B. Cohen, Susan T. Arnold, et al.. (1986). Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.. PubMed. 46(9). 4479–85. 17 indexed citations
15.
Cohen, Marvin B. & Robert I. Glazer. (1985). Inhibition of Interleukin‐2 Messenger RNA in Mouse Lymphocytes by 2′‐Deoxycoformycin and Adenosine Metabolites. Annals of the New York Academy of Sciences. 451(1). 180–187. 5 indexed citations
16.
Graham, Laura, R. Lake, & Marvin B. Cohen. (1984). REMOVAL OF SEPTAL PENETRATION EFFECTS IN IMAGES OBTAINED WITH HIGH PURITY I-123. Clinical Nuclear Medicine. 9(Supplement 9). 32–32. 1 indexed citations
17.
Cohen, Marvin B., Jonathan Maybaum, & Wolfgang Sadée. (1980). Analysis of purine ribonucleotides and deoxyribonucleotides in cell extracts by high-performance liquid chromatography. Journal of Chromatography A. 198(4). 435–441. 21 indexed citations
18.
Poe, N.D., et al.. (1977). Application of Delayed Lung Imaging Following Radioaerosol Inhalation. Radiology. 122(3). 739–746. 1 indexed citations
19.
Weiß, Peter, et al.. (1968). Masters and Innocents. The Hudson Review. 21(3). 522–522.
20.
Cohen, Marvin B.. (1968). Pericardial Effusion in Chronic Uremia. Archives of Internal Medicine. 122(5). 404–404. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Pollow Breakdown of academic impact, for papers by Tohru Yamazaki Breakdown of academic impact, for papers by Sylvie G. Bernier Breakdown of academic impact, for papers by Thomas Schöndorf Breakdown of academic impact, for papers by Aarti Asnani Breakdown of academic impact, for papers by Vojtech Ličko Breakdown of academic impact, for papers by Mari Ishida Breakdown of academic impact, for papers by Takeo Tanaka Breakdown of academic impact, for papers by A J Farrell Breakdown of academic impact, for papers by Xin Wei
Rankless by CCL
2026